Last updated on September 2nd, 2019 at 11:14 am
Qualifying for Medical Cannabis
Under the Texas Compassionate Use Act, certain patients with qualifying conditions including:
- epilepsy and other seizure conditions
- multiple sclerosis
- ALS and other neurodegenerative conditions, and
- terminal cancer
may legally obtain forms of low-THC medical cannabis products from state-licensed dispensaries.
To qualify for medical cannabis, patients who are permanent residents of Texas and diagnosed with newly expanded qualifying conditions must obtain a prescription from a qualified physician who determines the risk of low-THC cannabis is reasonable in light of the potential benefit for the patient.
Qualified physicians must be board-certified in a medical specialty relevant to the approved medical conditions by a specialty board approved by the American Board of Medical Specialties or the Bureau of Osteopathic Specialists.
The bill also calls for the Department of Health and Human Services Commission to determine the precise definition of “incurable neurodegenerative diseases” for which patients may be prescribed low-THC cannabis for medical use. The deadline for doing so is December 1, 2019.
Physicians will register their patient’s diagnosis and treatment plan with the state’s Compassionate Use Registry database. Once registered, patients and their legal guardians will be exempt from certain state laws prohibiting the possession of cannabis in Texas.
There is no age limit to qualify as a medical cannabis patient in Texas. However, patients under the age of 18 may require permission from a legal guardian.
If you are a patient looking to get medical cannabis prescribed in Texas you can see if your doctor is in the Compassionate Use Registry below.
If your doctor is not listed, please get in touch with Compassionate Cultivation and we’ll connect you with a certified prescriber.
If you’re looking for more information, you can visit one of the helpful links below:
For any questions or concerns, please feel free to get in touch with us at the form.